MedTrace Logo

Glioblastoma Remote Monitoring and Care - Research Protocol

NCT06129760 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2026-04-08

No results posted yet for this study

Summary

The purpose of this research is to learn more about how what the Apple watch measures, in terms of walking data, heart rate, breathing rate, and sleep habits, relates to how participants feel. During the course of the treatment, the symptoms participants experience change, and whether the Apple watch can detect these changes. Ultimately, this knowledge is being used to design proactive tools and signatures that can predict complications or symptom changes before they happen.

Conditions

Interventions

DEVICE

Apple Watch

The wearable sensor device is the Apple Watch Series 6 or newer

Sponsors & Collaborators

  • Case Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Andrew Dhawan, MD, DPhil · Brain Tumor Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

  • Rowan Barker-Clarke, PhD · Lerner Research Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

  • Siamrut Patanavanich · Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2026-10-31
Completion
2027-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06129760 on ClinicalTrials.gov